News

The National Agency for Food and Drugs Administration and Control has alerted the public to the discovery of an unregistered batch of Tarivid 200mg in Nigeria.According to a statement released on ...
The sky-high tariffs imposed by the United States and retaliatory tariffs by China and some other countries hurt global stock ...
Sanofi (NASDAQ: SNY) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Berenberg Bank analyst Luisa Hector ...
On June 9, Regeneron Pharmaceuticals and Sanofi (NASDAQ:SNY) announced promising interim results from the open-label Phase 4 ...
(Reuters) -Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune ...
Looking at licensing deals struck in the past 10 years, Jefferies found that many Big Pharmas do not ultimately follow ...
Merck’s Enflonsia will go up against Sanofi and AstraZeneca’s Beyfortus, which the partners plan to ship out early in the ...
Merck (MRK) stock is in focus as its Enflonsia RSV shot is cleared for infants in the U.S. in a market led by Sanofi (SNY) ...
Known as Enflonsia, the drug will compete for market share with Sanofi and AstraZeneca’s in-demand Beyfortus, which quickly ...
Merck’s shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.
In an effort to greater prepare HCPs and to avoid potential shortages, the company targets Q3 as the shipment date.